BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 21084964)

  • 1. Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up.
    Wynveen CA; Nehhozina T; Akram M; Hassan M; Norton L; Van Zee KJ; Brogi E
    Am J Surg Pathol; 2011 Jan; 35(1):1-14. PubMed ID: 21084964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
    Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
    Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.
    Esposito NN; Dabbs DJ; Bhargava R
    Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.
    Rakha EA; Gandhi N; Climent F; van Deurzen CH; Haider SA; Dunk L; Lee AH; Macmillan D; Ellis IO
    Am J Surg Pathol; 2011 Aug; 35(8):1093-103. PubMed ID: 21753694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast intracystic papillary carcinoma: an update.
    Calderaro J; Espie M; Duclos J; Giachetti S; Wehrer D; Sandid W; Cahen-Doidy L; Albiter M; Janin A; de Roquancourt A
    Breast J; 2009; 15(6):639-44. PubMed ID: 19735389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
    von Minckwitz G; Untch M; Blohmer JU; Costa SD; Eidtmann H; Fasching PA; Gerber B; Eiermann W; Hilfrich J; Huober J; Jackisch C; Kaufmann M; Konecny GE; Denkert C; Nekljudova V; Mehta K; Loibl S
    J Clin Oncol; 2012 May; 30(15):1796-804. PubMed ID: 22508812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
    Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
    Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
    Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
    Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
    Kapoor NS; Shamonki J; Sim MS; Chung CT; Giuliano AE
    Ann Surg Oncol; 2013 Aug; 20(8):2576-81. PubMed ID: 23468047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare coexistence of invasive papillary carcinoma with infiltrating ductal carcinoma in male breast: report of a case.
    Bhatia A; Uma Nahar Saikia ; Kumar Y
    Int J Surg Pathol; 2008 Jul; 16(3):311-3. PubMed ID: 18573787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
    Kuo SH; Chen CL; Huang CS; Cheng AL
    Anticancer Res; 2000; 20(3B):2219-22. PubMed ID: 10928181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
    Aryandono T; Harijadi ; Ghozali A
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
    Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
    Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone.
    Carter D; Orr SL; Merino MJ
    Cancer; 1983 Jul; 52(1):14-9. PubMed ID: 6850536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study.
    Leal C; Costa I; Fonseca D; Lopes P; Bento MJ; Lopes C
    Hum Pathol; 1998 Oct; 29(10):1097-104. PubMed ID: 9781648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer in very young women.
    Liukkonen S; Leidenius M; Saarto T; Sjöström-Mattson J
    Eur J Surg Oncol; 2011 Dec; 37(12):1030-7. PubMed ID: 21937191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male breast cancer: a survey at the Helsinki University Central Hospital during 1981-2006.
    Liukkonen S; Saarto T; Mäenpää H; Sjöström-Mattson J
    Acta Oncol; 2010 Apr; 49(3):322-7. PubMed ID: 20397767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity.
    Walsh MM; Bleiweiss IJ
    Hum Pathol; 2001 Jun; 32(6):583-9. PubMed ID: 11431712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.